HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (15) , 4626-4637
Abstract
Tamoxifen is a commonly used drug to treat estrogen receptor-positive patients with breast cancer. Despite the outstanding efficacy of tamoxifen, approximately one-third of patients develop resistance toward it, thereby presenting a therapeutic challenge. HOX genes may be involved in the acquisition of tamoxifen resistance. In this study, we identified HOXA5, a member of the HOX gene family, as a marker of tamoxifen resistance. Using ChIP assay, we found that HOXA5 expression was significantly overexpressed in tamoxifen-resistant MCF7 (TAMR) breast cancer cells because of reduced H3K27me3 binding. HOXA5 upregulation resulted in activation of the PI3K/AKT signaling cascade, which in turn, led to p53 and p21 reduction, ultimately making the TAMR cells less apoptotic. Furthermore, elevated HOXA5 expression resulted in breast cancer cells acquiring more mesenchymal-like and stem cell traits associated with aggressive breast cancer phenotypes. In conclusion, our results delineate a mechanism by which HOXA5 promotes tumorigenesis, cancer progression, and tamoxifen resistance in breast cancer cells.Keywords
This publication has 49 references indexed in Scilit:
- Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherinPLOS ONE, 2013
- Chromatin organization and global regulation of Hox gene clustersPhilosophical Transactions of the Royal Society B: Biological Sciences, 2013
- HOX genes in ovarian cancerJournal of Ovarian Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Influence of Hoxa5 on p53 Tumorigenic Outcome in MiceThe American Journal of Pathology, 2010
- Uncoupling Time and Space in the Collinear Regulation of Hox GenesPLOS Genetics, 2009
- Origins of breast cancer subtypes and therapeutic implicationsNature Clinical Practice Oncology, 2007
- Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of MllProceedings of the National Academy of Sciences, 2006
- Modulating Hox gene functions during animal body patterningNature Reviews Genetics, 2005
- The Hallmarks of CancerCell, 2000